Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) EBITDA (2020 - 2025)

Historic EBITDA for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $732000.0.

  • LifeStance Health's EBITDA rose 10934.99% to $732000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.9 million, marking a year-over-year increase of 9000.2%. This contributed to the annual value of -$58.8 million for FY2024, which is 6858.62% up from last year.
  • Latest data reveals that LifeStance Health reported EBITDA of $732000.0 as of Q3 2025, which was up 10934.99% from -$4.1 million recorded in Q2 2025.
  • LifeStance Health's EBITDA's 5-year high stood at $732000.0 during Q3 2025, with a 5-year trough of -$120.5 million in Q3 2021.
  • In the last 5 years, LifeStance Health's EBITDA had a median value of -$35.5 million in 2023 and averaged -$40.4 million.
  • As far as peak fluctuations go, LifeStance Health's EBITDA plummeted by 355670.92% in 2021, and later surged by 10934.99% in 2025.
  • Quarter analysis of 5 years shows LifeStance Health's EBITDA stood at -$108.0 million in 2021, then skyrocketed by 56.89% to -$46.6 million in 2022, then decreased by 1.01% to -$47.0 million in 2023, then skyrocketed by 85.22% to -$7.0 million in 2024, then surged by 110.53% to $732000.0 in 2025.
  • Its last three reported values are $732000.0 in Q3 2025, -$4.1 million for Q2 2025, and $392000.0 during Q1 2025.